MiMedx Group, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.1M | $221.7M | $187.3M | $118.2M | $59.2M | $27.1M | $7.8M | $788.9K |
| Cost of Revenue | $35.2M | $30.9M | $20.2M | $12.7M | $9.3M | $5.2M | $3.4M | $1.7M |
| Gross Profit | $285.9M | $190.8M | $167.1M | $105.6M | $49.9M | $21.9M | $4.4M | $-931.2K |
| Gross Margin | 89.0% | 86.0% | 89.2% | 89.3% | 84.2% | 80.8% | 56.7% | -118.0% |
| Operating Expenses | ||||||||
| Research & Development | $17.9M | $14.3M | $8.4M | $7.1M | $4.8M | $2.9M | $3.0M | $2.8M |
| SG&A Expense | $220.1M | $173.4M | $133.4M | $90.5M | $46.2M | $19.6M | $9.8M | $6.8M |
| Operating Income | $46.2M | $884.0K | $24.4M | $7.1M | $-2.6M | $-5.4M | $-9.8M | $-10.5M |
| Operating Margin | 14.4% | 0.4% | 13.0% | 6.0% | -4.5% | -19.8% | -125.8% | -1,335.2% |
| Interest Expense | — | $339.0K | $86.0K | $48.0K | $45.0K | $593.0K | $117.8K | $599.6K |
| Pretax Income | $45.1M | $545.0K | $24.3M | $7.1M | $-4.0M | $-7.7M | $-10.2M | $-11.4M |
| Income Tax Expense | $-19.6M | $155.0K | $-5.2M | $832.0K | $100.0K | $0 | $0 | $0 |
| Net Income | $64.7M | $390.0K | $29.4M | $6.2M | $-4.1M | $-7.7M | $-10.2M | $-11.4M |
| Net Margin | 20.2% | 0.2% | 15.7% | 5.3% | -6.9% | -28.3% | -131.4% | -1,447.6% |
| EPS (Basic) | $0.61 | $0.00 | $0.28 | $0.06 | $-0.04 | $-0.09 | $-0.14 | $-0.19 |
| EPS (Diluted) | $0.56 | $0.00 | $0.26 | $0.05 | $-0.04 | $-0.09 | $-0.14 | $-0.19 |
| Shares Outstanding (Basic) | 106.1M | 105.9M | 105.9M | 105.8M | 96.3M | 81.6M | 72.5M | 64.3M |
| Shares Outstanding (Diluted) | 116.1M | 112.6M | 113.6M | 113.3M | 96.3M | 81.6M | 72.5M | 64.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |